Josep Julve
About
Josep Julve is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Molecular Biology.
According to data from OpenAlex, Josep Julve has authored 133 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Surgery, 47 papers in Endocrinology, Diabetes and Metabolism and 40 papers in Molecular Biology. Recurrent topics in Josep Julve's work include Cholesterol and Lipid Metabolism (35 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (34 papers) and Lipoproteins and Cardiovascular Health (30 papers). Josep Julve is often cited by papers focused on Cholesterol and Lipid Metabolism (35 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (34 papers) and Lipoproteins and Cardiovascular Health (30 papers). Josep Julve collaborates with scholars based in Spain, United States and Finland. Josep Julve's co-authors include Francisco Blanco‐Vaca, Joan Carles Escolà‐Gil, Jesús M. Martín‐Campos, Jordi Ordóñez‐Llanos, Francesc González‐Sastre, Noemí Rotllán, Lídia Cedó, José Luís Sánchez-Quesada, Julia Peinado‐Onsurbe and Gemma Llaverı́as and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and PLoS ONE.
In The Last Decade
Josep Julve
129 papers receiving 2.4k citations
Peers
Josep Julve
Daisaku Masuda Japan
Kyriakos E. Kypreos Greece
Saša Frank Austria
Monica Gomaraschi Italy
Víctor Grijalva United States
Thomas Gautier France
Maria Pia Adorni Italy
Diego Gómez‐Coronado Spain
Makoto Ayaori Japan
David W. Garber United States
Citations per year, relative to Josep Julve Josep Julve (= 1×)
peers
Daisaku Masuda
Countries citing papers authored by Josep Julve
Since
Specialization
Citations
This map shows the geographic impact of Josep Julve's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Josep Julve with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Josep Julve more than expected).
Fields of papers citing papers by Josep Julve
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Josep Julve. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Josep Julve. The network helps show where Josep Julve may publish in the future.
Co-authorship network of co-authors of Josep Julve
This figure shows the co-authorship network connecting the top 25 collaborators of Josep Julve. A scholar is included among the top collaborators of Josep Julve based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Josep Julve. Josep Julve is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Amigó, Núria, Esmeralda Castelblanco, Josep Julve, et al.. (2025). Advanced serum lipoprotein and glycoprotein profiling for cardiovascular event prediction in type 2 diabetes mellitus: the LIPOCAT study. Cardiovascular Diabetology. 24(1). 88–88.
2.
Julve, Josep, Esmeralda Castelblanco, Julia Ponomarenko, et al.. (2025). Fecal Short-Chain Fatty Acids to Predict Prediabetes and Type 2 Diabetes Risk: An Exploratory Cross-Sectional Study. Nutrients. 17(18). 3003–3003.
3.
García‐Osuna, Álvaro, Inka Miñambres, Ignasi Gich, et al.. (2025). Association of Epicardial Adipose Tissue with Novel Inflammation and Heart Failure Biomarkers in Type 2 Diabetes Patients: Effect of Metabolic Control. Journal of Clinical Medicine. 14(13). 4687–4687.
4.
García‐Osuna, Álvaro, Inka Miñambres, Ignasi Gich, et al.. (2025). Low-Density Lipoprotein Subfraction Phenotype Is Associated with Epicardial Adipose Tissue Volume in Type 2 Diabetes. Journal of Clinical Medicine. 14(3). 862–862.
5.
Vlacho, Bogdan, et al.. (2025). Hypertriglyceridemia and its relationship with all-cause mortality and pancreatitis: Results from a large retrospective clinical registry. Journal of clinical lipidology. 19(4). 922–930.
6.
Castelblanco, Esmeralda, Óscar Yanes, Ralf J. M. Weber, et al.. (2024). The Lipidomic Profile Is Associated with the Dietary Pattern in Subjects with and without Diabetes Mellitus from a Mediterranean Area. Nutrients. 16(12). 1805–1805.
7.
Vendrell, Pere, Minerva Granado-Casas, Eduardo Martelli Moreira, et al.. (2024). Impact of Dietary Niacin on Metabolic Dysfunction-Associated Steatotic Liver Disease in Mediterranean Subjects: A Population-Based Study. Nutrients. 16(23). 4178–4178.
8.
Bermúdez-López, Marcelino, Gerard Torres, Reinald Pamplona, et al.. (2024). Mediterranean Diet Is a Predictor of Progression of Subclinical Atherosclerosis in a Mediterranean Population: The ILERVAS Prospective Cohort Study. Nutrients. 16(21). 3607–3607.
9.
Garcı́a, Eduardo, Inka Miñambres, Claudia Velásquez, et al.. (2023). Increased sLRP1 and decreased atrial natriuretic peptide plasma levels in newly diagnosed T2DM patients are normalized after optimization of glycemic control. Frontiers in Endocrinology. 14. 1236487–1236487.
10.
Meier‐Credo, Jakob, Josep Julve, Noemí Rotllán, et al.. (2023). Essential protein P116 extracts cholesterol and other indispensable lipids for Mycoplasmas. Nature Structural & Molecular Biology. 30(3). 321–329.
11.
Julve, Josep, Paola Quifer‐Rada, Óscar Yanes, et al.. (2023). Circulating metabolomic and lipidomic changes in subjects with new-onset type 1 diabetes after optimization of glycemic control. Diabetes Research and Clinical Practice. 197. 110578–110578.
12.
Granado-Casas, Minerva, et al.. (2022). Effectiveness of medical nutrition therapy in adolescents with type 1 diabetes: a systematic review. Nutrition and Diabetes. 12(1). 24–24.
13.
Canyelles, Marina, Antonio Pérez, Alexandra Junza, et al.. (2022). Divergent Effects of Glycemic Control and Bariatric Surgery on Circulating Concentrations of TMAO in Newly Diagnosed T2D Patients and Morbidly Obese. Diagnostics. 12(11). 2783–2783.
14.
Castelblanco, Esmeralda, Jordi Real, Marta Hernández, et al.. (2021). Advanced Quantitative Lipoprotein Characteristics Do Not Relate to Healthy Dietary Patterns in Adults from a Mediterranean Area. Nutrients. 13(12). 4369–4369.
15.
Canyelles, Marina, Álvaro García‐Osuna, Alexandra Junza, et al.. (2021). The Capacity of APOB-Depleted Plasma in Inducing ATP-Binding Cassette A1/G1-Mediated Macrophage Cholesterol Efflux—But Not Gut Microbial-Derived Metabolites—Is Independently Associated with Mortality in Patients with ST-Segment Elevation Myocardial Infarction. Biomedicines. 9(10). 1336–1336.
16.
Rull, Anna, David Santos, Núria Puig, et al.. (2020). Subcutaneous Administration of Apolipoprotein J-Derived Mimetic Peptide d-[113–122]apoJ Improves LDL and HDL Function and Prevents Atherosclerosis in LDLR-KO Mice. Biomolecules. 10(6). 829–829.
17.
Farré, Núria, David Santos, Jari Metso, et al.. (2019). Human ApoA-I Overexpression Enhances Macrophage-Specific Reverse Cholesterol Transport but Fails to Prevent Inherited Diabesity in Mice. International Journal of Molecular Sciences. 20(3). 655–655.
18.
Blanco‐Vaca, Francisco, Jesús M. Martín‐Campos, Marina Canyelles, et al.. (2019). Molecular analysis of APOB, SAR1B, ANGPTL3, and MTTP in patients with primary hypocholesterolemia in a clinical laboratory setting: Evidence supporting polygenicity in mutation-negative patients. Atherosclerosis. 283. 52–60.
19.
Santos, David, Núria Farré, Sergi Leánez, et al.. (2018). Administration of CORM-2 inhibits diabetic neuropathy but does not reduce dyslipidemia in diabetic mice. PLoS ONE. 13(10). e0204841–e0204841.
20.
Julve, Josep, et al.. (2000). Diagnóstico de hiperquilomicronemia familiar debida a deficiencia de lipoproteinlipasa: estudio clínico, bioquímico y genético de un caso y análisis de las mutaciones identificadas en otros 10 casos. Clínica e Investigación en Arteriosclerosis. 12(4). 191–198.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Daisaku Masuda Breakdown of academic impact, for papers by Kyriakos E. Kypreos Breakdown of academic impact, for papers by Saša Frank Breakdown of academic impact, for papers by Monica Gomaraschi Breakdown of academic impact, for papers by Víctor Grijalva Breakdown of academic impact, for papers by Thomas Gautier Breakdown of academic impact, for papers by Maria Pia Adorni Breakdown of academic impact, for papers by Diego Gómez‐Coronado Breakdown of academic impact, for papers by Makoto Ayaori Breakdown of academic impact, for papers by David W. Garber